Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 166 AL 180

Application of a clinical scale for predicting Aβ-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment

Lahiri D, Kathir S, Punjwani Z, Liu A, Pasvanis S, Seixas-Lima B, Roncero CT, Chertkow H; COMPASS-ND investigators.

J Neurol Sci. 2026 Sep 15;488:126047. doi: 10.1016/j.jns.2026.126047. Epub 2026 Jun 8.

Reduced diffusion associated with amyloid-related imaging abnormalities in three patients treated with donanemab

Schwartz NU, Dietz CD, Lin Z, Tammewar G, Bui N, La Joie R, Wang Y, Sreekrishnan A, Suhami D, VandeVrede L, Ljubenkov PA, Rojas JC.

Neurocase. 2026 Aug;32(4):174-179. doi: 10.1080/13554794.2026.2695021. Epub 2026 Jul 2.

Evaluating digital cognitive tests for clinical use in Alzheimer's disease: A novel framework and scoping review

Hampel H, Nakamura Y, Bell J, Hendrix S, Derchansky M, Montezano BB, Stoeckel LE, Teipel S, Willis DR, Cummings JL, Cobb BR.

Alzheimers Dement. 2026 Aug;22(8):e71559. doi: 10.1002/alz.71559.

rTMS modulates early AD progression via synergistic brain network reorganization and peripheral biomarker dynamics

Wang T, Guo M, Wu H, Liu S, Ji Y, Wang P, Xu G.

Geroscience. 2026 Jun;48(3):4295-4311. doi: 10.1007/s11357-025-01888-z. Epub 2025 Sep 27.

Alzheimer's disease diagnosis: An update and review of biomarkers, positron emission tomography, and emerging therapies

Chen PH, Hsu JL.

J Formos Med Assoc. 2026 Jun;125 Suppl 1:S13-S16. doi: 10.1016/j.jfma.2026.01.035. Epub 2026 Jan 27.

Prognostic value of plasma NfL and GFAP for conversion to Alzheimer's disease and dementia in MCI: a systematic review and robust Bayesian meta-analysis

Özkurt Ç, Kelicen-Uğur P.

Biomarkers. 2026 Jun;31(4):326-338. doi: 10.1080/1354750X.2026.2633568. Epub 2026 Jun 18.

Rational Use of Blood-Based Biomarkers for Alzheimer's Disease: Navigating Between the Hope and the Hype

Reuben DB, Chambliss AB, Katz BJ, López AS, Hinman JD.

J Am Geriatr Soc. 2026 Jun;74(6):1543-1547. doi: 10.1111/jgs.70384. Epub 2026 Mar 19.

The role of olfactory and salivary gland pathways in periodontal disease-mediated Alzheimer's disease progression: mechanistic insights and early diagnostic implications

Liang H, Yu W, Han Z, Xu B, Zhuang Z, Liu J.

Acta Clin Belg. 2026 Aug;81(4):330-346. doi: 10.1080/17843286.2026.2652268. Epub 2026 Apr 4.

Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial

Dhana K, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL.

J Alzheimers Dis. 2026 Jun;111(3):1301-1308. doi: 10.1177/13872877261442856. Epub 2026 Apr 25.

Peripheral biomarkers of neuroinflammation in Alzheimer's disease and vascular dementia

Ouyang X, Chia RSL, Chai YL, Chong JR, Sim MA, Jo DG, Arumugam TV, Sethi G, Dawe GS, Chen CP, Lai MKP.

Biochem Pharmacol. 2026 Aug;250(Pt 2):118077. doi: 10.1016/j.bcp.2026.118077. Epub 2026 May 17.

Biomarkers in preclinical and early Alzheimer's disease in China: a scoping review

Peng G, Yang Y, Wang Y, Chandekar SA, Yu J.

J Prev Alzheimers Dis. 2026 Aug;13(7):100599. doi: 10.1016/j.tjpad.2026.100599. Epub 2026 May 19.

The gut-brain axis in Alzheimer's and Parkinson's diseases: a systematic review of microbiota-derived biomarkers and novel therapeutic approaches

Singh VK, Gupta P, Jain SK, Matreja PS.

J Clin Exp Neuropsychol. 2026 Aug;48(6):606-621. doi: 10.1080/13803395.2026.2673084. Epub 2026 Jun 2.

Blood-based biomarkers for early diagnosis of Alzheimer's disease: a current systematic review of diagnostic accuracy studies

Efe JJ, Anibor E, Pandey P, Sunday OG, Innocent DC, Anyakorah PE, Emmanuel OI.

BMC Neurol. 2026 Jun 5;26(1):502. doi: 10.1186/s12883-026-05046-6.

Omics-driven strategies for identifying biomarkers in Alzheimer's disease

Khan Y, Rekha A, Ballal S, Maharana L, Maqbool M, Goyal K, Mishra R, Uniyal P, Alam P, Aljarba TM, Gupta G, Hussain MS.

Metab Brain Dis. 2026 Jun 6;41(1):128. doi: 10.1007/s11011-026-01873-1.

Plasma p-tau as a biomarker for the differential diagnosis of Alzheimer's disease: a systematic review and meta-analysis

Chai L, Zhan Y, Huang Y, Tian M, Zhao G, Ni J, Xiong X, Huang J, Lin B.

Alzheimers Res Ther. 2026 Jun 8;18(1):186. doi: 10.1186/s13195-026-02104-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias